JFIL 最新10-Q变化
将 JFIL 最新的定期申报(10-K/10-Q)与上一份同类型申报逐章节对比:每个章节新增/删除的段落数与原文摘录。全部为确定性文本对比——无相似度评分、无方向判断、非投资建议。
对比:10-Q · 2026-07-13 与上一份 10-Q · 2026-01-13
| 章节 | 结果 | 新增 | 删除 | 微调 | 未变 |
|---|---|---|---|---|---|
| 管理层讨论与分析 | 文字有新增/删除 | +10 | −10 | ~7 | 5 |
| 市场风险(第3项) | 无段落级文字变化 | 0 | 0 | 0 | 1 |
| 控制与程序 | 文字有新增/删除 | 0 | 0 | ~1 | 0 |
| 法律诉讼 | 文字有新增/删除 | 0 | 0 | ~1 | 0 |
计数单位为段落;"新增/删除"指相对上一份文件新增/删除的文字,不含方向或好坏判断。
未列出(无法可靠提取或缺失):风险因素、其他信息
代表性摘录
每个章节最多 5 条、每条约 300 字符的原文摘录,直接来自两份 SEC 文件。
管理层讨论与分析
相对上期新增的文字 · 来源:10-Q · 2026-07-13
From the third quarter of the year ended February 29, 2020, the Company began its new business line of providing technical support services for development of new nutrition food products to sell to customers in USA. However, this new business line remained pre-revenue throughout the quarter ended at…
No other expenses incurred during the three-month periods ended May 31, 2026 and 2025.
For the three months ending May 31, 2026, we recognized a net loss of $29,731 compared to the net loss of $19,190 for the corresponding period in 2025.
As of May 31, 2026, the Company had current assets of $9,725, primarily comprising of cash of $1,715 and prepaid expenses of $8,010, and current liabilities of $1,459,548, resulting in a working capital deficit of $1,449,823. The Company had limited profitable operation activities and has an accumul…
Our net cash used in operating activities increased by $15,178 in the three months ended May 31, 2026 compared to the net cash used in operating activities in the three months ending May 31, 2025. The increase in net cash used in operating activities was primarily due to higher net loss of $10,541 i…
相对上期删除的文字 · 来源:10-Q · 2026-01-13
From the third quarter of the year ended February 29, 2020, the Company began providing technical support services for development of new nutrition food products to sell to customers in USA. No significant revenue has been generated from this new business line.
For the nine months ended November 30, 2025 compared to the nine months ended November 30, 2024
The major components of our operating expenses for the nine months ended November 30, 2025 and 2024 are outlined in the table below:
The $628 increase in our operating costs for the nine months ended November 30, 2025 compared to nine months ended November 30, 2024, was mainly due to an increase in OTC service expense of $450 and an increase of $207 in professional fee.
No other expenses incurred during the three and nine-month periods ended November 30, 2025 and 2024.
如何读 10-Q 的风险因素(第 1A 项)
10-Q 的风险因素章节有三种常见形态,本页按其一分类展示:
- 指向(pointer) — 公司仅声明"无重大变化"并指向年度 10-K 的完整风险因素;本季没有自己的风险文本可对比。
- 部分更新(partial) — 公司写明"除下述外无重大变化",只更新部分风险;摘录展示的正是本季新增的内容。
- 全文重述(restated) — 本季重新给出完整风险因素。若上一季只是"指向",则无法逐段对比,本页会将其标为"本季全文重述"。
这只是对文件结构的客观描述,不构成对风险高低的判断。
数据来自 SEC EDGAR 两份申报文件的文本级对比 · 确定性计算(无 AI 生成内容)· 仅供参考 · 非投资建议